(Q43099191)

English

Front-line bevacizumab in serous epithelial ovarian cancer: biomarker analysis of the FINAVAST trial

scientific article published in March 2010

Statements

Front-line bevacizumab in serous epithelial ovarian cancer: biomarker analysis of the FINAVAST trial (English)
Peeter Karihtala
Johanna Mäenpää
Taina Turpeenniemi-Hujanen
Ulla Puistola
1 March 2010
1001-1006

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit